CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...